XTL Biopharmaceuticals Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$1,782 over the previous period. Total operating expenses were $765,000.
Profit Margin
| 2014 | 41K | -2.52M | -6163.41% |
|---|---|---|---|
| 2015 | -6K | -4.31M | 71850% |
| 2016 | 23K | -2.54M | -11065.22% |
| 2017 | 29K | -781K | -2693.1% |
| 2018 | 52K | 2.98M | 5742.31% |
| 2019 | 69K | -1.27M | -1852.17% |
| 2020 | 28K | -616K | -2200% |
| 2021 | 1.46M | 1.90M | 129.67% |
| 2022 | -459K | -2.30M | 503.05% |
| 2023 | 0 | -1.78K |
XTLB Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | -459K | 1.46M | 28K | 69K | 52K | 29K | 23K | -6K | 41K |
Cost of revenue | 0 | 1K | 1K | 1K | 0 | 0 | 1K | 2.99K | 7K | 17 |
Gross profit | 0 | -460K | 1.46M | 27K | 69K | 52K | 28K | 20K | -13K | 40.98K |
Operating exp. | ||||||||||
Research and development | 31K | 30K | 30K | 38K | 35K | 38K | 43K | 443K | 578K | 278K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 765K | 880K | 1.03M | 948K | 842K | 793K | 1.24M | 1.71M | 1.99M | 2.02M |
Operating income | -765K | -880K | -1.03M | -948K | -842K | -793K | -1.24M | -2.56M | -3.61M | -2.02M |
Other income (expenses), net | -1.01M | -468K | 1.46M | -2.00M | -505K | 3.69M | 465K | -848K | -1.62M | -97K |
Income before tax | -1.78M | -1.34M | 435K | -782K | -1.34M | 2.98M | -781K | -2.54M | -3.62M | -2.11M |
Income tax expense | 0 | 961K | -1.46M | -166K | -69K | -7.63M | -457K | 832K | 2.31M | 505K |
Net income | -1.78K | -2.30M | 1.90M | -616K | -1.27M | 2.98M | -781K | -2.54M | -4.31M | -2.52M |
Earnings per share | ||||||||||
Basic EPS | 0 | -0.42 | 0.36 | -0.12 | -0.25 | 0.58 | -0.17 | -0.93 | -1.63 | -1.09 |
Diluted EPS | 0 | -0.42 | 0.31 | -0.12 | -0.25 | 0.58 | -0.17 | -0.93 | -1.63 | -1.09 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |